Kazia Therapeutics Limited
5 clinical trials · Sponsor
◉ Watch Kazia Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male Subjects (NCT05012670) | Kazia Therapeutics Limited | 2021-08-18 |
| Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma (NCT03522298) | Kazia Therapeutics Limited | 2018-05-15 |
Track Kazia Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.